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Introduction: Innate immune system dysfunction has been recognized as an important 
element in the pathophysiology of bipolar disorder (BD). The aim of this study was to 
investigate a different aspect of immunity, e.g. the pattern of macrophage polarization, 
classic (M1) or alternative (M2), and examine how this pattern changes from early to 
late stages of BD.  
Methods: Human monocytes purified from PBMC of patients with BD and healthy 
individuals were differentiated with M-CSF. Monocyte-derived macrophages (MDM) 
were exposed to IFN-γ plus LPS or to IL-4 to induce their polarization into the M1 or M2 
phenotype, respectively and the secretion of cytokines (IL-1β, IL-6, IL-10 and TNF-α) 
was used as index of macrophage activity.  
Results: Macrophages from BD patients in the late stage secreted lower levels of IL-1β 
(M1), IL-6 (M0, M1 and M2) and IL-10 (M0 and M1) compared to early stage group. 
Additionally, BD patients in late stage had lower secretion of IL-1β (M0 e M1), IL-6 (M0, 
M1 and M2), TNF-α (M0, M1 and M2) and IL-10 (M1) than healthy controls. In contrast, 
there were no significant differences in cytokine levels in the macrophages (M0, M1 and 
M2) from early BD patients compared to healthy controls.  
Conclusion: Our results point to a dysfunction in the innate immune compartment of 
BD patients in the late stages of illness. We hypothesize that persistent 
microenvironmental and systemic changes that occur during the progression of the 
disease, might promote exhaustion of the immune system. In this regard, it is plausible 
to speculate that this failure of the immune system to regulate and counterbalance a 
peripheral inflammatory response may contribute to structural and neurocognitive 
changes commonly observed in the advanced stages of the illness. 
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